Sheryl Sandberg, plus open-source AI gene editing explained
2024-05-03 spoken.md · speaker-labeled ▶ watch ← E176 all episodes E178 →
Every number here is replayed from score_events — the same ledger the pool ranks on. Decay is what the 135 ideas nobody mentioned gave up this week; it applies only when an episode is processed.
Tier crossings
conviction thresholds crossed by this episode — 65 / 45 / 15 · ideas born here show where they landed. why 65 isn't always green
Kill dates that landed since E176
2 hit · 1 partial · 0 miss — windows that closed after 2024-04-26 and up to 2024-05-03, auto-scored against price data and never hand-set. verdict · R · α
| idea | verdict | R | α | closed |
|---|---|---|---|---|
| 📈 Amazon's ad business passes AWS within three years | PARTIAL | +5.7% | -19.3 | 2024-05-01 |
| 🤖 AI collapses the cost of knowledge work to ten cents on the dollar | HIT | +33.3% | +9.4 | 2024-04-28 |
| 📈 Cellular meat is uneconomic this cycle - alternative protein is a value trap | HIT | +52.7% | +28.8 | 2024-04-28 |
Who moved the board
each voice's force on conviction this episode — supports and opposes, weighted exactly as the replay applied them · share = % of this episode's movement
What got argued (1 idea)
ordered by how hard each idea moved · quotes are verbatim from the transcript, timestamps deep-link into the episode
ProFluent Bio trained a protein language model on 26 trillion bases and generated OpenCRISPR-1, a Cas protein 400 mutations from anything in nature that outperforms Cas9 and was released under an open-source licence. Friedberg's read: AI can now design around the Broad/MIT/Berkeley CRISPR patent estate, so the core editing toolkit goes free and ubiquitous the way Linux and HTML5 replaced paid stacks, the royalty and licence friction stops gating startups, and the value in gene editing accrues to applications across human health, agriculture and industrial biotech rather than to the tool IP.
There's a simple truth to all this, which is every single life sciences lab on Earth is using this technology today. It has absolutely revolutionized life sciences. It has changed everything. It has reset the trajectory of human health, of agriculture, and of industrial biotechnology.
Episode digest
written during extraction and stored in data/extractions/ep177.json — the auditable source of truth, including everything market-adjacent that did not earn a capture
Almost the entire episode is a non-market interview with Sheryl Sandberg about her October 7 sexual-violence documentary and campus protests; the besties explicitly cut the business block short ("We didn't get to talk about anything business") and Sacks was absent on a board meeting. The only tradeable content is the post-break science corner on ProFluent Bio's OpenCRISPR-1: a protein language model trained on 26 terabases generated a novel Cas protein 400 mutations from anything in nature, tested better than Cas9, and was open-sourced, which Friedberg frames as AI routing around the Broad/MIT CRISPR patent estate and freeing the core gene-editing toolkit the way HTML5 killed Flash licence fees. He calls gene editing already ubiquitous and says it has reset the trajectory of human health, agriculture and industrial biotech; he expects the patent question to be litigated later and wants more open tools. Jason's only market-adjacent note is that AI will make truth harder to establish in war coverage — directional but with no instrument, so not captured. DIARIZATION WARNING: Chamath is merged into the David Friedberg label for the interview portion (his own label holds only 10 short quips, all in the cold open plus 52:43); Jason addresses a Friedberg-labelled turn as Chamath at 45:18, 51:42 and 56:50, and Sheryl does the same at 15:34. No captures were taken from that window, and the science corner (1:00:15 onward) is verified Friedberg by content.